Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Yang-Chun Du · SciRah

Researcher profile · Semantic Scholar

Yang-Chun Du

Share profile

Yang-Chun Du — researcher profile on SciRah

h-index: 18
Works: 53
Citations: 3,174

Most-cited papers

Genome-wide Analysis of Genetic Loci Associated with Alzheimer’s Disease
S. Seshadri, A. Fitzpatrick, M. Ikram, A. Destefano +59 more
2010Journal of the American Medical Association (JAMA)1,244 citations Open access
Semantic Scholar
Genomewide Association Studies of Stroke
M. Ikram, S. Seshadri, J. Bis, M. Fornage +42 more
2009New England Journal of Medicine471 citations Open access
Semantic Scholar
Depressive symptoms and cognitive decline in late life: a prospective epidemiological study.
M. Ganguli, Yang-Chun Du, H. Dodge, G. Ratcliff +1 more
2006Archives of General Psychiatry332 citations Open access
Semantic Scholar
Opioid Modulation With Buprenorphine/Samidorphan as Adjunctive Treatment for Inadequate Response to Antidepressants: A Randomized Double-Blind Placebo-Controlled Trial.
M. Fava, A. Memişoğlu, M. Thase, J. Bodkin +7 more
2016American Journal of Psychiatry166 citations Open access
Semantic Scholar
Evaluation of Opioid Modulation in Major Depressive Disorder
E. Ehrich, R. Turncliff, Yang-Chun Du, Richard A Leigh-Pemberton +3 more
2014Neuropsychopharmacology163 citations Open access
Semantic Scholar
A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia.
H. Meltzer, R. Risinger, H. Nasrallah, Yang-Chun Du +6 more
2015Journal of Clinical Psychiatry121 citations Open access
Semantic Scholar
Cognitive domains and trajectories of functional independence in nondemented elderly persons.
H. Dodge, Yang-Chun Du, J. Saxton, M. Ganguli
2006The journals of gerontology. Series A, Biological sciences and medical sciences111 citations Open access
Semantic Scholar
Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study.
C. Correll, J. Newcomer, B. Silverman, Lauren DiPetrillo +7 more
2020American Journal of Psychiatry103 citations
Semantic Scholar
Relative bioavailability and safety of aripiprazole lauroxil, a novel once-monthly, long-acting injectable atypical antipsychotic, following deltoid and gluteal administration in adult subjects with schizophrenia.
R. Turncliff, M. Hard, Yang-Chun Du, R. Risinger +1 more
2014Schizophrenia Research43 citations
Semantic Scholar
Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia.
H. Nasrallah, J. Newcomer, R. Risinger, Yang-Chun Du +5 more
2016Journal of Clinical Psychiatry35 citations
Semantic Scholar
The Framingham Heart Study Clock Drawing Performance: Normative Data from the Offspring Cohort
Justin A Nyborn, J. Himali, A. Beiser, S. Devine +8 more
2013Experimental Aging Research32 citations Open access
Semantic Scholar
Effect of aripiprazole lauroxil on agitation and hostility in patients with schizophrenia
L. Citrome, Yang-Chun Du, R. Risinger, S. Stankovic +5 more
2016International Clinical Psychopharmacology31 citations
Semantic Scholar
Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia
H. Nasrallah, R. Aquila, Yang-Chun Du, Arielle D. Stanford +2 more
2018CNS Spectrums24 citations Open access
Semantic Scholar
White Matter Hyperintensity and Cognitive Functioning in the Racial and Ethnic Minority Cohort of the Framingham Heart Study
Karina Stavitsky, Yang-Chun Du, D. Seichepine, Thomas M. Laudate +5 more
2010Neuroepidemiology24 citations Open access
Semantic Scholar
Discrepancies in information provided to primary care physicians by patients with and without dementia: the Steel Valley Seniors Survey.
M. Ganguli, Yang-Chun Du, Eric G. Rodriguez, B. Mulsant +4 more
2006The American journal of geriatric psychiatry23 citations
Semantic Scholar
Pharmacokinetic Evaluation of a 1-Day Treatment Initiation Option for Starting Long-Acting Aripiprazole Lauroxil for Schizophrenia
M. Hard, Angela Y. Wehr, Yang-Chun Du, P. Weiden +2 more
2018Journal of Clinical Psychopharmacology19 citations Open access
Semantic Scholar
Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Study
P. Weiden, Yang-Chun Du, L. von Moltke, Angela Y. Wehr +3 more
2020CNS Drugs18 citations Open access
Semantic Scholar
Effect of hepatic and renal impairment on the pharmacokinetics of olanzapine and samidorphan given in combination as a bilayer tablet
Lei Sun, Sergey Yagoda, Yang-Chun Du, L. von Moltke
2019Drug Design, Development and Therapy18 citations Open access
Semantic Scholar
Pharmacokinetics and safety of deltoid or gluteal injection of aripiprazole lauroxil NanoCrystal® Dispersion used for initiation of the long-acting antipsychotic aripiprazole lauroxil
M. Hard, Angela Y. Wehr, L. von Moltke, Yang-Chun Du +3 more
2019Therapeutic Advances in Psychopharmacology18 citations Open access
Semantic Scholar
Efficacy and Safety of a 2-Month Formulation of Aripiprazole Lauroxil With 1-Day Initiation in Patients Hospitalized for Acute Schizophrenia Transitioned to Outpatient Care: Phase 3, Randomized, Double-Blind, Active-Control ALPINE Study.
P. Weiden, A. Claxton, J. Kunovac, D. Walling +6 more
2020Journal of Clinical Psychiatry16 citations
Semantic Scholar
Effect of aripiprazole lauroxil in patients with acute schizophrenia as assessed by the Positive and Negative Syndrome Scale—supportive analyses from a Phase 3 study
L. Citrome, R. Risinger, A. Cutler, Yang-Chun Du +3 more
2017CNS Spectrums15 citations
Semantic Scholar
Durability of Therapeutic Response With Long-Term Aripiprazole Lauroxil Treatment Following Successful Resolution of an Acute Episode of Schizophrenia.
J. Mcevoy, R. Risinger, Serhiy Mykhnyak, Yang-Chun Du +3 more
2017Journal of Clinical Psychiatry14 citations Open access
Semantic Scholar
Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study.
C. Correll, Arielle D. Stanford, A. Claxton, Yang-Chun Du +1 more
2019Psychiatry Research13 citations Open access
Semantic Scholar
Effects of the Opioid System Modulator, Samidorphan, on Measures of Alcohol Consumption and Patient‐Reported Outcomes in Adults with Alcohol Dependence
S. O'Malley, M. Todtenkopf, Yang-Chun Du, E. Ehrich +1 more
2018Alcoholism: Clinical and Experimental Research13 citations
Semantic Scholar
Efficacy and safety of aripiprazole lauroxil in schizophrenic patients presenting with severe psychotic symptoms during an acute exacerbation.
S. Potkin, R. Risinger, Yang-Chun Du, J. Zummo +4 more
2017Schizophrenia Research12 citations Open access
Semantic Scholar
Effect of patient age on treatment response in a study of the acute exacerbation of psychosis in schizophrenia.
S. Targum, R. Risinger, Yang-Chun Du, J. Pendergrass +2 more
2017Schizophrenia Research11 citations
Semantic Scholar
Analysis of prolactin and sexual side effects in patients with schizophrenia who switched from paliperidone palmitate to aripiprazole lauroxil.
D. Kelly, A. Claxton, I. Bidollari, Yang-Chun Du
2021Psychiatry Research10 citations Open access
Semantic Scholar
Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study
H. Nasrallah, P. Weiden, D. Walling, Yang-Chun Du +3 more
2021BMC Psychiatry9 citations Open access
Semantic Scholar
Application and prospect of artificial intelligence in diagnostic imaging of prostate cancer
Xiao-Xiao Wang, Shan Zhong, Kun Fang, Yang-Chun Du +1 more
2026npj Digital Medicine8 citations Open access
Semantic Scholar
ARTISTRY-1: Nemvaleukin alfa monotherapy and in combination with pembrolizumab in patients (pts) with advanced solid tumors.
V. Boni, I. Winer, L. Gilbert, U. Vaishampayan +16 more
20218 citations
Semantic Scholar
Aripiprazole Lauroxil Dosing Regimens: Understanding Dosage Strengths and Injection Intervals
R. Sommi, B. Rege, Angela Y. Wehr, Sejal Faldu +2 more
2020CNS Spectrums8 citations Open access
Semantic Scholar
Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label study.
B. Miller, A. Claxton, Yang-Chun Du, P. Weiden +1 more
2019Schizophrenia Research7 citations Open access
Semantic Scholar
Selection of the recommended phase 2 dose (RP2D) for subcutaneous nemvaleukin alfa: ARTISTRY-2.
O. Hamid, Stephen V. Liu, R. Boccia, Justin Call +16 more
2021Journal of Clinical Oncology6 citations
Semantic Scholar
Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm
L. Citrome, Yang-Chun Du, P. Weiden
2019Neuropsychiatric Disease and Treatment5 citations Open access
Semantic Scholar
Switching stable patients with schizophrenia from their oral antipsychotics to aripiprazole lauroxil: a post hoc safety analysis of the initial 12-week crossover period
P. Weiden, Yang-Chun Du, Chih-Chin Liu, Arielle D. Stanford
2018CNS Spectrums5 citations Open access
Semantic Scholar
Nemvaleukin alfa in patients with advanced renal cell carcinoma: ARTISTRY-1.
E. Calvo, V. Boni, A. Chaudhry, P. Debruyne +8 more
2022Journal of Clinical Oncology4 citations
Semantic Scholar
167 Randomized, Double-Blind, Active-Controlled Study of Starting Aripiprazole Lauroxil with 1-Day Initiation in Acutely Ill Patients with Schizophrenia
Peter J. Weiden, A. Claxton, Yang-Chun Du, Sergey Yagoda +2 more
2020CNS Spectrums4 citations Open access
Semantic Scholar
Beyond 52-Week Long-Term Safety: Long-Term Outcomes of Aripiprazole Lauroxil for Patients With Schizophrenia Continuing in an Extension Study.
J. Lauriello, A. Claxton, Yang-Chun Du, P. Weiden
2020Journal of Clinical Psychiatry4 citations Open access
Semantic Scholar
ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients (pts) with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.
T. Herzog, K. Moore, P. Konstantinopoulos, L. Gilbert +11 more
2022Journal of Clinical Oncology2 citations
Semantic Scholar
M105. ACTIGRAPHIC MONITORING OF SLEEP-WAKE CYCLE IN SCHIZOPHRENIA OUTPATIENTS RECEIVING A LONG-ACTING INJECTABLE ANTIPSYCHOTIC: FEASIBILITY AND INITIAL RESULTS FROM A PROSPECTIVE RCT
Sergey Yagoda, R. Wolz, P. Weiden, A. Claxton +2 more
2020Schizophrenia bulletin2 citations Open access
Semantic Scholar
63 Long-term Outcomes with Aripiprazole Lauroxil for the Treatment of Schizophrenia: A 2-Year, Phase 3, Multicenter Extension Study
P. Weiden, A. Claxton, Yang-Chun Du, J. Lauriello
2019CNS Spectrums2 citations Open access
Semantic Scholar
F197. Aripiprazole Lauroxil NanoCrystal® Dispersion: A Potential 1-Day Initiation Regimen for Long-Acting Aripiprazole Lauroxil
D. Walling, M. Hard, Angela Y. Wehr, Yang-Chun Du +2 more
20182 citations
Semantic Scholar
373 Phase 1/2 study of subcutaneously administered ALKS 4230, a novel engineered cytokine, as monotherapy and in combination with pembrolizumab, in patients with advanced solid tumors: ARTISTRY-2
J. Powderly, B. Carthon, M. Ernstoff, A. Olszanski +12 more
2020Journal for ImmunoTherapy of Cancer1 citations Open access
Semantic Scholar
Repeated Measures Analysis of the Sequential Parallel Comparison Design With Normal Responses
K. Lu, Yang-Chun Du
2020Statistics in Biopharmaceutical Research1 citations
Semantic Scholar
347 Clinical outcomes of ovarian cancer patients treated with ALKS 4230, a novel engineered cytokine, in combination with pembrolizumab: ARTISTRY-1 trial
I. Winer, L. Gilbert, U. Vaishampayan, S. Rosen +24 more
20201 citations Open access
Semantic Scholar
CNS volume 27 issue 3 Cover and Front matter
S. Stahl, R. Sommi, B. Rege, Angela Y. Wehr +2 more
2022CNS Spectrums0 citations Open access
Semantic Scholar
Aripiprazole Lauroxil 2-Month Formulation With 1-Day Initiation for Acute Schizophrenia: ALPINE Exploratory Efficacy and Patient-Reported Outcomes.
H. Nasrallah, D. Walling, P. Weiden, Yang-Chun Du +3 more
2021CNS Spectrums0 citations Open access
Semantic Scholar
100 Olanzapine/Samidorphan for Schizophrenia: Weight Gain and Metabolic Outcomes in Phase 3 ENLIGHTEN-2 and Subsequent Long-Term, Open-Label Safety Study
C. Correll, J. Newcomer, B. Silverman, Lauren DiPetrillo +7 more
2020CNS Spectrums0 citations Open access
Semantic Scholar
S195. Improvement in Prolactin and Sexual Side Effects in Patients With Schizophrenia Who Switched From Paliperidone Palmitate or Risperidone Long-Acting Injectable to Aripiprazole Lauroxil
D. Kelly, A. Claxton, I. Bidollari, Yang-Chun Du +1 more
2019Biological Psychiatry0 citations
Semantic Scholar
F2. CHANGE IN PROLACTIN AND SEXUAL SIDE EFFECTS IN PATIENTS WITH SCHIZOPHRENIA WHO SWITCHED FROM PALIPERIDONE PALMITATE OR RISPERIDONE LONG-ACTING INJECTION TO ARIPIPRAZOLE LAUROXIL
D. Kelly, A. Claxton, I. Bidollari, Yang-Chun Du
2019Schizophrenia bulletin0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Weiden×16
Invite
P. Weiden — researcher profile on SciRah
A. Claxton×14
Invite
A. Claxton — researcher profile on SciRah
B. Silverman×10
Invite
B. Silverman — researcher profile on SciRah
E. Ehrich×8
Invite
E. Ehrich — researcher profile on SciRah

×8

Invite

R. Risinger — researcher profile on SciRah

Invite

D. Walling — researcher profile on SciRah

I. Bidollari×7

Invite

I. Bidollari — researcher profile on SciRah

H. Nasrallah×6

Invite

H. Nasrallah — researcher profile on SciRah

Angela Y. Wehr×6

Invite

Angela Y. Wehr — researcher profile on SciRah

Sergey Yagoda×6

Invite

Sergey Yagoda — researcher profile on SciRah

Invite

J. Zummo — researcher profile on SciRah

Invite

M. Hard — researcher profile on SciRah